Research
Cellular
INV-202 was well tolerated with no serious or severe treatment-emergent adverse events.
INV-202 appears to be a safe option for individuals with metabolic syndrome.
StrongSupportsmedium confidence
INV-202 was well tolerated with no serious or severe treatment-emergent adverse events.
Why this rating
Based on study design from abstract.
Source
Effects of <scp>CB1R</scp> inverse agonist, <scp>INV</scp> ‐202, in patients with features of metabolic syndrome. A randomized, placebo‐controlled, double‐blind phase 1b study
Glenn Crater et al. · Diabetes Obesity and Metabolism · 2023
DOI 10.1111/dom.15353
rct · n=37Cited 40×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Cellular
- Athletes aiming to reduce fat mass and preserve FFM should consume protein intakes in the range of ∼1.8-2.7 g kg(-1) d(-1).Strong
- A minimum daily protein intake of ≥1.6 g/kg is necessary to observe significant improvements in muscle mass from whey protein supplementation.Strong
- Most athletes ideally need 1.2 to 2.0 grams/kg of body weight/day of protein, preferably split across 3-4 meals.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →